FY2024 Earnings Estimate for Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Issued By Leerink Partnrs

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) – Research analysts at Leerink Partnrs lowered their FY2024 EPS estimates for Walgreens Boots Alliance in a research report issued to clients and investors on Thursday, June 27th. Leerink Partnrs analyst M. Cherny now forecasts that the pharmacy operator will post earnings per share of $2.86 for the year, down from their previous estimate of $3.19. The consensus estimate for Walgreens Boots Alliance’s current full-year earnings is $2.94 per share. Leerink Partnrs also issued estimates for Walgreens Boots Alliance’s Q3 2025 earnings at $0.58 EPS.

A number of other equities analysts have also recently issued reports on the stock. Morgan Stanley lowered their price objective on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating for the company in a research report on Friday. Raymond James reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Tuesday, March 26th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a research report on Wednesday, April 3rd. SVB Leerink reduced their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a report on Monday, March 18th. Finally, JPMorgan Chase & Co. reduced their price target on shares of Walgreens Boots Alliance from $30.00 to $20.00 and set an “overweight” rating for the company in a report on Monday. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $19.00.

Walgreens Boots Alliance Stock Performance

NASDAQ WBA opened at $11.58 on Monday. The firm has a 50-day moving average price of $16.49 and a two-hundred day moving average price of $20.14. The company has a market capitalization of $10.00 billion, a P/E ratio of -1.72, a P/E/G ratio of 0.82 and a beta of 0.72. The company has a quick ratio of 0.31, a current ratio of 0.65 and a debt-to-equity ratio of 0.49. Walgreens Boots Alliance has a 12-month low of $11.48 and a 12-month high of $31.32.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $0.63 EPS for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). The firm had revenue of $36.40 billion during the quarter, compared to the consensus estimate of $35.94 billion. Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The business’s revenue was up 2.8% on a year-over-year basis. During the same period last year, the business earned $1.00 EPS.

Institutional Trading of Walgreens Boots Alliance

Institutional investors have recently bought and sold shares of the stock. Fulton Bank N.A. grew its stake in Walgreens Boots Alliance by 0.5% in the fourth quarter. Fulton Bank N.A. now owns 107,071 shares of the pharmacy operator’s stock valued at $2,796,000 after purchasing an additional 523 shares during the last quarter. Insight Folios Inc lifted its holdings in Walgreens Boots Alliance by 5.8% in the fourth quarter. Insight Folios Inc now owns 9,640 shares of the pharmacy operator’s stock valued at $252,000 after acquiring an additional 525 shares during the period. Atlas Brown Inc. lifted its holdings in Walgreens Boots Alliance by 1.8% in the first quarter. Atlas Brown Inc. now owns 31,593 shares of the pharmacy operator’s stock valued at $685,000 after acquiring an additional 550 shares during the period. Pinnacle Financial Partners Inc raised its stake in shares of Walgreens Boots Alliance by 4.9% during the 4th quarter. Pinnacle Financial Partners Inc now owns 11,866 shares of the pharmacy operator’s stock worth $310,000 after buying an additional 555 shares during the period. Finally, Westpac Banking Corp increased its position in shares of Walgreens Boots Alliance by 10.1% during the fourth quarter. Westpac Banking Corp now owns 6,100 shares of the pharmacy operator’s stock worth $159,000 after purchasing an additional 560 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors.

Insider Activity at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari acquired 3,000 shares of the stock in a transaction dated Thursday, April 11th. The shares were purchased at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the purchase, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The acquisition was disclosed in a filing with the SEC, which is available at this link. 17.40% of the stock is currently owned by insiders.

Walgreens Boots Alliance Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st were given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 8.64%. The ex-dividend date was Monday, May 20th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is -14.84%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.